RxDoctor Payments Data

Ralph Cox, MD

Family Medicine · Dallas, TXNPI 1922071703

Payments from drug & device makers

$1,236,459in general payments, 2019–2025

Across 256 payments — averaging $4829.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$936K
  • Seqirus USA Inc$281K
  • Alnylam Pharmaceuticals Inc.$11K
  • Pfizer$8K
  • Indivior Inc.$578
  • Abbott$105
  • plus $243 from 6 others
$150in research payments, 2019–2025

Across 1 payment — averaging $150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Indivior Inc.$150

What the payments were for

  • Food & beverage$925100%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,236,459 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$385,540
Medicare patients
355
Services billed
7,604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide18$29,371
ShingrixVaricella-Zoster Ge/As01b/Pf105$23,134
JardianceEmpagliflozin16$21,224
SuboxoneBuprenorphine Hcl/Naloxone Hcl24$19,235
AbrysvoRsv Vacc, Pref A And Pref B/Pf61$19,184
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl111$16,105
EliquisApixaban16$14,813
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf37$2,350
Boostrix TdapDiphth,pertuss(Acell),tet Vac26$1,813
Alcohol PadsAlcohol Antiseptic Pads20$1,721
Gabapentin43$1,051
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$885
Pregabalin25$870
Bupropion XlBupropion Hcl15$582
Levothyroxine Sodium44$516

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerAbrysvo, Eliquis$7,639$33,99777 claims
Novo NordiskOzempic$33$29,37118 claims
Indivior Inc.Suboxone$578$19,23524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →